NCT05788211View on ClinicalTrials.gov

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Cardiogenic ShockRenal Replacement TherapyVenoarterial Extracorporeal Membrane Oxygenation
Interventions
OTHER

standard of care

retrospective study: standard of care

Trial Locations (1)

33604

Bordeaux University Hospital, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT05788211 - REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO) | Biotech Hunter | Biotech Hunter